Antipsychotic use in pregnancy and risk of attention/deficit-hyperactivity disorder and autism spectrum disorder: a Nordic cohort study

Autor: Johan Reutfors, Øystein Karlstad, Siri E. Håberg, Helle Kieler, Sinna Pilgaard Ulrichsen, Maarit K. Leinonen, Kari Furu, Oskar Halfdanarson, Helga Zoega, Kristjana Einarsdóttir, Jacqueline M. Cohen, Vidar Hjellvik, Carolyn E. Cesta, Buket Ozturk Essen, Mika Gissler, Marte-Helene Bjork, Mette Nørgaard

Publikováno v: Evidence-Based Mental Health
Hálfdánarson, Ó, Cohen, J M, Karlstad, Ø, Cesta, C E, Bjørk, M-H, Håberg, S E, Einarsdóttir, K, Furu, K, Gissler, M, Hjellvik, V, Kieler, H, Leinonen, M K, Nørgaard, M, Esen, B Ö, Ulrichsen, S P, Reutfors, J & Zoega, H 2022, ' Antipsychotic use in pregnancy and risk of attention/deficit-hyperactivity disorder and autism spectrum disorder : a Nordic cohort study ', Evidence-Based Mental Health, vol. 25, no. 2, pp. 54-62 . https://doi.org/10.1136/ebmental-2021-300311

BackgroundAntipsychotics are increasingly used among women of childbearing age and during pregnancy.ObjectiveTo determine whether children exposed to antipsychotics in utero are at increased risk of attention-deficit/hyperactivity disorder (ADHD) or

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::99c1989f679ab4d4bad19aeae040af75
https://doi.org/10.1136/ebmental-2021-300311